Eargo, Inc. EAR
2.57 0.00 (+0.00%)
At closeFeb 15, 2024, 4:00 PM EST
2.56 Day range 2.64
52-week range unavailable
- Market cap
- 53.36M
- Revenue (ttm)
- 41.11M
- Profit margin
- -263.14%
- Shares out
- 20.76M
- Forward P/E
- -0.05
- Volume
- 201.27K
- Open
- 2.62
- Previous close
- 2.57
- Day's range
- 2.56 – 2.64
- Beta
- 1.48
- Analysts
- Hold
- Earnings date
- Mar 28, 2024
No chart data for this range yet.
Key statistics
- Enterprise value
- 14.99M
- PEG ratio
- 0.00
- Price / sales
- 1.30
- Price / book
- 1.18
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 4.60%
- Free cash flow
- -44.07M
- Total cash
- 46.02M
- Total debt
- 7.65M
- Return on equity
- -2457.08%
- Short % of float
- 0.86%
- 50-day average
- 2.62
- 200-day average
- 3.13
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Mar 28, 2024
Expected Mar 28, 2024. Consensus EPS estimate 0.00.
Financials — quick view
EAR Revenue — quarterly 8.27M
EAR Net income — quarterly -17.33M
EAR EPS — quarterly -0.83
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -0.97 | — | — | — |
| May 11, 2023 | Mar 1, 2023 | -1.90 | — | — | — |
| Mar 23, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | -10.20 | — | — | — |
About Eargo, Inc.
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- eargo.com
News
Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients 
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings 
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Eargo, Inc. 
Wolf Popper LLP Investigates the Acquisition of Eargo, Inc. by Its Controlling Shareholder, Patient Square Capital 
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm 
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm 
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm 
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR 
Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation
Your note
Sign in to keep a note on EAR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWNIE WILLIAM H | Chief Executive Officer | Sale | Aug 16, 2023 | 6,779 |
| GILDE HEALTHCARE HOLDING B.V. | Former | Sale | Apr 26, 2021 | 0 |
| GORMSEN CHRISTIAN | Chief Executive Officer | Sale | May 16, 2023 | 6,065 |
| HUGHES DOUGLAS J | Director | Conversion of Exercise of derivative security | Nov 21, 2022 | 107,072 |
| LAPONIS ADAM | Chief Financial Officer | Sale | Nov 19, 2023 | 258 |
| MAKHZOUMI MOHAMAD | Beneficial Owner of more than 10% of a Class of Security | Sale | May 24, 2021 | 4,520,020 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Patient Square Capital LP | 76.25% | 15,821,299 | 78.00M | Jun 29, 2023 |
| Blackrock Inc. | 1.17% | 242,883 | 1.20M | Jun 29, 2023 |
| NEA Management Company, LLC | 1.00% | 207,886 | 1.02M | Jun 29, 2023 |
| Nan Fung Group Holdings Limited | 0.71% | 147,904 | 729.17K | Jun 29, 2023 |
| Vanguard Group Inc | 0.41% | 85,290 | 420.48K | Jun 29, 2023 |
| Nantahala Capital Management, LLC | 0.26% | 54,002 | 266.23K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.21% | 43,485 | 214.38K | Jun 29, 2023 |
| Vanguard Total Stock Market Index Fund | 0.20% | 40,636 | 200.34K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.11% | 23,106 | 109.98K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.07% | 13,634 | 64.90K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 10,658 | 50.73K | May 30, 2023 |
| iShares Micro Cap ETF | 0.05% | 11,385 | 31.54K | Aug 30, 2023 |